Modern Management of Borderline Resectable Pancreatic Cancer

Treatment of Stage 1-2 Pancreas Cancer with surgery and multimodality therapy is the most beneficial to patients with this disease. Most patients present with borderline resectable pancreatic cancer are amenable to surgery. This talk will discuss the standardization for pathological staging and operative reporting of surgery for borderline resectable pancreas cancer with particular attention to mulitimodality treatment.

Target Audience

Physicians who wish to learn more about the latest surgical treatments and clinical trial protocols for pancreatic cancer treatment.

  • Physicians: Medical doctors, gastroenterologists, general surgeons, internists, pathologists and primary care physicians
  • Medical oncologists
  • Physician assistants
  • Nurse practitioners
  • Residents and Medical students

Learning Objectives

  • Become familiar with nomenclature for resectable, borderline, and locally advanced pancreatic cancer
  • Enhance the communication between surgeon and pathologist when reporting pancreatic cancer findings
  • Develop standardized synoptic operating report and pathology reports
  • Consider multimodality treatment for borderline resectable pancreatic cancer
  • Understand the most important anatomical elements to be reported in operative notes and pathology reports for surgeons caring for pancreatic cancer patients

Policy on Faculty and Provider Disclosure

It is the policy of Beth Israel Medical Center and St. Luke's and Roosevelt Hospitals that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. Beth Israel Medical Center and St. Luke's and Roosevelt Hospitals have established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following have reported that they do not have any financial relationships to disclose:
Steven Brower, MD


Steven T. Brower, MD

Steven T. Brower, MD Steven T. Brower, MD, Vice-Chairman of the Department of Surgery, and Chief, Division of Surgical Oncology at Beth Israel Medical Center, is a nationally recognized cancer and gastrointestinal surgeon.
View Full Profile